Company Filing History:
Years Active: 2004-2011
Title: Innovations and Contributions of Eric LaCasse
Introduction
Eric LaCasse is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of six patents to his name, LaCasse has focused on methods and compositions that enhance therapeutic outcomes for patients with proliferative diseases.
Latest Patents
Among his latest patents is a method for treating cancer using IAP antisense oligomer and chemotherapeutic agents. This invention features methods, compositions, and kits designed to treat patients suffering from proliferative diseases. Another significant patent is related to antisense IAP nucleobase oligomers, which hybridize to IAP polynucleotide. This invention provides methods for using these oligomers to enhance apoptosis and treat various proliferative disorders.
Career Highlights
LaCasse has worked with prominent organizations such as Aegera Therapeutics, Inc. and the University of Ottawa. His work in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Daniel McManus and Jon P Durkin. Their collaborative efforts have further advanced the research and development of innovative cancer treatments.
Conclusion
Eric LaCasse's contributions to cancer treatment through his patents and collaborations highlight his dedication to improving patient outcomes. His work continues to inspire advancements in medical research and innovation.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.